NuPulse, Inc is a medical device company that is developing novel technology to treat patients with heart failure, one of the leading causes of death worldwide. The device, which requires a minimally invasive surgery, provides patients an alternative to medical therapy. NuPulse has a strategic and financial partnership with one of the leading heart failure companies in the world. NuPulse’s founders have extensive clinical, engineering and life science experience, which will allow them, along with their strategic partner and Broadview Ventures, to alter the paradigm for the treatment of heart failure.